
Opinion|Podcasts|December 23, 2024
Navigating Lifestyle and Pharmacotherapy Interventions in Dyslipidemia Management
Key Takeaways
Panelists discuss how lifestyle interventions, including diet, physical activity, and smoking cessation, complement pharmacotherapy in the management of dyslipidemia, and explore unmet needs in cardiovascular risk reduction, highlighting the role of emerging therapies such as bempedoic acid, inclisiran, and gene editing technologies.
Advertisement
Navigating Lifestyle and Pharmacotherapy Interventions in Dyslipidemia Management
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
Diabetes Increases Mortality Risk Across All Major Organ Transplants
2
What Are Some Clinical Pearls in Pediatric Dermatology? With Lisa Swanson, MD
3
Plasma EV Analysis Identifies Proteins Associated With T1D Risk, With Ernesto Nakayasu, PhD
4
How to Counsel Patients About Skincare Safety, Sunscreen Safety, and Product Ingredients
5



























































